Latest filing published 28 Oct 2025 for NEOGEN CORP, €206k. Read the official filing
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by John Edward Adent on record concern Neogen Corp. Over a trading history stretching from 29 July 2022 to 27 October 2025, the count stands at 22 filings.
On the market, this insider has only ever bought: 5 purchases, €1.4M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 6 share grants and 9 option exercises. Since January 2025: 1 purchase and no sales on the market.
A typical purchase (the median) is worth €265k. 4 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 50% of cases; the median change was +8.7%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 28 October 2025 with an option exercise (€206k) in Neogen Corp. The most recent open-market purchase was published on 16 January 2025, 640 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations